$OPGN
OPGEN INC Stock $opgn

$opgn Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000114420415065342 Filed on November 13, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$1.330M	$980.8K	$834.8K
YoY Change	18.75%	17.48%
Cost Of Revenue	$640.0K	$562.7K	$101.4K
YoY Change	146.15%	454.79%
Gross Profit	$690.0K	$371.5K	$604.3K
YoY Change	-19.77%	-38.53%
Gross Profit Margin	51.88%	37.87%	72.38%
Selling, General & Admin	$3.640M	$2.591M	$1.015M
YoY Change	222.12%	155.35%
% of Gross Profit	527.54%	697.39%	167.89%
Research & Development	$2.260M	$1.724M	$1.030M
YoY Change	111.21%	67.45%
% of Gross Profit	327.54%	464.15%	170.39%
Depreciation & Amortization	$230.0K	$185.2K	$141.1K
YoY Change	109.09%	31.28%	-69.99%
% of Gross Profit	33.33%	49.85%	23.34%
Operating Expenses	$5.510M	$5.025M	$2.185M
YoY Change	150.45%	129.97%
Operating Profit	-$4.820M	-$4.654M	-$1.581M
YoY Change	259.7%	194.38%
Interest Expense	-$40.00K	$17.48K	$32.33K
YoY Change	-33.33%	-45.93%
% of Operating Profit
Other Income/Expense, Net		-$14.97K	-$27.89K
YoY Change		-46.34%
Pretax Income	-$4.860M	-$4.669M	-$1.610M
YoY Change	244.68%	190.0%
Income Tax	-$130.0K	$1.662K	$0.00
% Of Pretax Income
Net Earnings	-$4.730M	-$4.671M	-$1.609M
YoY Change	235.46%	190.31%
Net Earnings / Revenue	-355.64%	-476.21%	-192.72%
Basic Earnings Per Share
Diluted Earnings Per Share	-$157.7M	-$155.7M	-$80.50M
COMMON SHARES
Basic Shares Outstanding	12.54M shares	12.54M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.810M	$11.19M	$780.0K
YoY Change	941.33%	1334.62%
Cash & Equivalents	$7.814M	$11.19M	$781.6K
Short-Term Investments
Other Short-Term Assets	$570.0K	$540.0K	$90.00K
YoY Change	533.33%	500.0%
Inventory	$826.0K	$1.155M	$380.0K
Prepaid Expenses
Receivables	$678.6K	$553.9K	$180.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.885M	$13.43M	$1.440M
YoY Change	476.9%	832.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.075M	$1.022M	$700.0K
YoY Change	82.79%	46.0%
Goodwill	$637.5K	$291.7K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$270.3K	$290.0K	$60.00K
YoY Change	370.47%	383.33%
Total Long-Term Assets	$3.871M	$3.565M	$770.0K
YoY Change	311.21%	363.0%
TOTAL ASSETS
Total Short-Term Assets	$9.885M	$13.43M	$1.440M
Total Long-Term Assets	$3.871M	$3.565M	$770.0K
Total Assets	$13.76M	$17.00M	$2.210M
YoY Change	418.15%	669.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.286M	$1.270M	$900.0K
YoY Change	97.04%	41.11%
Accrued Expenses	$920.3K	$2.070M	$1.620M
YoY Change	-4.9%	27.78%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$250.0K	$230.0K	$110.0K
YoY Change	127.27%	109.09%
Total Short-Term Liabilities	$4.590M	$3.735M	$4.130M
YoY Change	-23.77%	-9.57%
LONG-TERM LIABILITIES
Long-Term Debt	$1.320M	$1.320M	$160.0K
YoY Change	915.38%	725.0%
Other Long-Term Liabilities	$350.0K
YoY Change
Total Long-Term Liabilities	$1.670M	$1.320M	$160.0K
YoY Change	1184.62%	725.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.590M	$3.735M	$4.130M
Total Long-Term Liabilities	$1.670M	$1.320M	$160.0K
Total Liabilities	$6.265M	$5.050M	$4.290M
YoY Change	1.78%	17.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$114.1M
YoY Change	17.93%
Common Stock	$125.5K
YoY Change	2444.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.491M	$11.94M	-$2.080M
YoY Change
Total Liabilities & Shareholders Equity	$13.76M	$17.00M	$2.210M
YoY Change	418.15%	669.12%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$4.730M	-$4.671M	-$1.609M
YoY Change	235.46%	190.31%
Depreciation, Depletion And Amortization	$230.0K	$185.2K	$141.1K
YoY Change	109.09%	31.28%	-69.99%
Cash From Operating Activities	-$3.210M	-$6.490M	-$1.310M
YoY Change	116.89%	395.42%	-78.8%
INVESTING ACTIVITIES
Capital Expenditures	-$100.0K	-$60.00K	-$10.00K
YoY Change		500.0%	-75.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.370M
YoY Change
Cash From Investing Activities	-$100.0K	$1.310M	-$10.00K
YoY Change		-13200.0%	-75.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-60.00K	6.160M	1.450M
YoY Change	-104.17%	324.83%	-1418.18%
NET CHANGE
Cash From Operating Activities	-3.210M	-6.490M	-1.310M
Cash From Investing Activities	-100.0K	1.310M	-10.00K
Cash From Financing Activities	-60.00K	6.160M	1.450M
Net Change In Cash	-3.370M	980.0K	130.0K
YoY Change	8325.0%	653.85%	-102.05%
FREE CASH FLOW
Cash From Operating Activities	-$3.210M	-$6.490M	-$1.310M
Capital Expenditures	-$100.0K	-$60.00K	-$10.00K
Free Cash Flow	-$3.110M	-$6.430M	-$1.300M
YoY Change	110.14%	394.62%	-78.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1021971	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	13434867	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	90233	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	993657	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	339171	USD
CY2014Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	296041	USD
	dei	Trading Symbol TradingSymbol	OPGN
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12539704	shares
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	553938	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	538312	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	1155488	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	503983	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11187129	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	17482	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	57459	USD
CY2014Q4	us-gaap	Assets Assets	2654931	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6021507	USD
CY2014Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	134149	USD
CY2014Q4	us-gaap	Liabilities Liabilities	6155656	USD
CY2014Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	4564899	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	4932	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	88701737	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-96772293	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-8065624	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16997489	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1160081	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	423099	USD
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	100499	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3734781	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2654931	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1250	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1505000	USD
CY2015Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2014Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1500000	USD
	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	1432592	USD
	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	841567	USD
	opgn	Laboratory Services Revenue LaboratoryServicesRevenue	87201	USD
	opgn	Laboratory Services Revenue LaboratoryServicesRevenue	379339	USD
	opgn	Collaborations Revenue CollaborationsRevenue	308340	USD
	opgn	Collaborations Revenue CollaborationsRevenue	1783340	USD
	us-gaap	Revenues Revenues	1828133	USD
	us-gaap	Revenues Revenues	3004246	USD
	us-gaap	Cost Of Goods Sold Excluding Depreciation Depletion And Amortization CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization	712016	USD
	us-gaap	Cost Of Goods Sold Excluding Depreciation Depletion And Amortization CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization	276831	USD
	us-gaap	Cost Of Services Excluding Depreciation Depletion And Amortization CostOfServicesExcludingDepreciationDepletionAndAmortization	191738	USD
	us-gaap	Cost Of Services Excluding Depreciation Depletion And Amortization CostOfServicesExcludingDepreciationDepletionAndAmortization	336616	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3741247	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3075420	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3687313	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1590085	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2815976	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10238157	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4222939	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9675	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4400	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	647342	USD
	us-gaap	Interest Expense InterestExpense	47468	USD
	us-gaap	Interest Expense InterestExpense	1746853	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	120	USD
	us-gaap	Operating Expenses OperatingExpenses	6613738	USD
	us-gaap	Operating Expenses OperatingExpenses	11162536	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1486801	USD
CY2014Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	40749	USD
CY2015Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	222031	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	362537	shares
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2384520	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6444373	shares
CY2015Q3	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	929241	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-42948	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-13.03
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12261238	shares
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	362537	shares
CY2014Q3	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	268854	USD
CY2015Q3	opgn	Laboratory Services Revenue LaboratoryServicesRevenue	23765	USD
CY2014Q3	opgn	Laboratory Services Revenue LaboratoryServicesRevenue	88190	USD
CY2015Q3	opgn	Collaborations Revenue CollaborationsRevenue	27780	USD
CY2014Q3	opgn	Collaborations Revenue CollaborationsRevenue	477780	USD
CY2015Q3	us-gaap	Revenues Revenues	980786	USD
CY2014Q3	us-gaap	Revenues Revenues	834824	USD
CY2015Q3	us-gaap	Cost Of Goods Sold Excluding Depreciation Depletion And Amortization CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization	562694	USD
CY2014Q3	us-gaap	Cost Of Goods Sold Excluding Depreciation Depletion And Amortization CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization	101425	USD
CY2015Q3	us-gaap	Cost Of Services Excluding Depreciation Depletion And Amortization CostOfServicesExcludingDepreciationDepletionAndAmortization	46634	USD
CY2014Q3	us-gaap	Cost Of Services Excluding Depreciation Depletion And Amortization CostOfServicesExcludingDepreciationDepletionAndAmortization	129120	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1724127	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1029650	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1610828	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	555444	USD
CY2015Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	979681	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4653951	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1580939	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2513	USD
CY2014Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4400	USD
CY2015Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	32331	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	37	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	2185218	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	5025409	USD
CY2014Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	459064	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14969	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27894	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.92
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-4670582	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-1608833	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12624339	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4265887	USD
CY2015Q3	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	0	USD
CY2014Q3	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	175246	USD
	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	244508	USD
	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	458799	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4670582	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1784079	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12868847	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4724686	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-78311	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-814855	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	29853	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1752790	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-42778	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-180311	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-121551	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-11071538	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3905198	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	89234	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39537	USD
	opgn	Proceeds From Issuance Of Convertible Notes And Warrants Net Of Issuance Costs ProceedsFromIssuanceOfConvertibleNotesAndWarrantsNetOfIssuanceCosts	1388815	USD
	opgn	Proceeds From Issuance Of Convertible Notes And Warrants Net Of Issuance Costs ProceedsFromIssuanceOfConvertibleNotesAndWarrantsNetOfIssuanceCosts	1472386	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1741667	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	1277977	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-39537	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1937902	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2015Q2	opgn	Proceeds From Issuance Of Units Under Initial Public Offering Gross ProceedsFromIssuanceOfUnitsUnderInitialPublicOfferingGross	17100000	USD
CY2015Q2	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	7374852	shares
CY2015Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	79697	USD
CY2015Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1500000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	71421	USD
CY2015Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	700000	USD
CY2015Q2	opgn	Stock Purchase Warrants Issued Upon Conversion Over Allotment Option StockPurchaseWarrantsIssuedUponConversionOverAllotmentOption	422500	shares
CY2015Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4225	USD
CY2015Q3	opgn	Future Minimum Royalty Payments Due FutureMinimumRoyaltyPaymentsDue	20000	USD
CY2015Q3	opgn	Royalty Income Expense RoyaltyIncomeExpense	-7484	USD
CY2014Q3	opgn	Royalty Income Expense RoyaltyIncomeExpense	-23810	USD
	opgn	Royalty Income Expense RoyaltyIncomeExpense	13769	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-507066	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-62251	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	3750	USD
	opgn	Repayments Of Capital Lease Obligations RepaymentsOfCapitalLeaseObligations	112200	USD
	opgn	Repayments Of Capital Lease Obligations RepaymentsOfCapitalLeaseObligations	80575	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	20231366	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3325963	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-288126	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	159174	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	306386	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1172231	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	80457	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	153750	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10437612	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-618772	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	429320	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
	opgn	Proceeds From Stock Options And Warrant Exercises ProceedsFromStockOptionsAndWarrantExercises	214	USD
	opgn	Proceeds From Stock Options And Warrant Exercises ProceedsFromStockOptionsAndWarrantExercises	0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	392404	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	461432	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	1598312	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	20883	USD
	us-gaap	Interest Paid InterestPaid	201233	USD
	us-gaap	Interest Paid InterestPaid	26088	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	781573	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1400345	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	12408285	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2015Q2	opgn	Stock And Warrants Issued During Period Shares Initial Public Offering StockAndWarrantsIssuedDuringPeriodSharesInitialPublicOffering	2850000	shares
CY2015Q2	opgn	Stock And Warrants Issued During Period Shares Initial Public Offering Purchase Price Per Unit StockAndWarrantsIssuedDuringPeriodSharesInitialPublicOfferingPurchasePricePerUnit	6.00
CY2015Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	697414	USD
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	135625	USD
CY2015Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	236043	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	193368	USD
CY2015Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	778944	USD
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	867816	USD
CY2015Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2750	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	11187129	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	749517	USD
	opgn	Royalty Income Expense RoyaltyIncomeExpense	-73142	USD
CY2013Q3	opgn	License Upfront Payment Received LicenseUpfrontPaymentReceived	250000	USD
	us-gaap	Licenses Revenue LicensesRevenue	208340	USD
CY2014Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-4517541	USD
	us-gaap	Licenses Revenue LicensesRevenue	1133340	USD
CY2015Q3	us-gaap	Licenses Revenue LicensesRevenue	27780	USD
CY2014Q2	us-gaap	Licenses Revenue LicensesRevenue	172220	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-49	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	371458	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	604279	USD
	us-gaap	Gross Profit GrossProfit	924379	USD
	us-gaap	Gross Profit GrossProfit	2390799	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-4668920	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-1608833	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-12622677	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-4265887	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1662	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1662	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	525596	USD
CY2014Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	525596	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-49	USD
CY2014Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-49	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4670631	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1608833	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12624388	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4265887	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12539704	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	493178	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	493178	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12539704	shares
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	1367211	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-193	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4958335	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Use of estimates</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, share-based compensation, allowances for doubtful accounts and inventory obsolescence, valuation of derivative financial instruments, beneficial conversion features of convertible debt, deferred tax assets and liabilities and related valuation allowance, and depreciation and amortization and estimated useful lives of long-lived assets, and the recoverability of long-lived assets. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	6631510	USD
CY2015Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1126530	USD
CY2014Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1955894	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-15623109	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-11784997	USD
CY2015Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-4650817	USD
CY2014Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	76267809	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1172231	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	80457	USD
CY2015Q3	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	1	pure
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	500000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	3902337	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	1500000	USD
CY2015Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	2100000	USD
CY2015Q2	opgn	Proceeds From Issuance Of Units Under Initial Public Offering Net ProceedsFromIssuanceOfUnitsUnderInitialPublicOfferingNet	12100000	USD
CY2014Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2750	USD
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5700000	shares
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5700000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6100000	shares
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	261540	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24977	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1662	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	79697	USD
CY2015Q1	opgn	Common Stock Percent CommonStockPercent	0.08	pure
CY2015Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1955769	USD
CY2014Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	0	USD
CY2015Q3	us-gaap	Goodwill Goodwill	291747	USD
CY2014Q4	us-gaap	Goodwill Goodwill	0	USD
CY2015Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	1000000	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	-44595	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	447007	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	341862	USD
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-2.29
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-11.72
CY2015Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.38
CY2014Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-4.49
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2584090	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	300000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2015Q3	opgn	Cost Of Sales Excluding Depreciation Depletion And Amortization CostOfSalesExcludingDepreciationDepletionAndAmortization	609328	USD
CY2014Q3	opgn	Cost Of Sales Excluding Depreciation Depletion And Amortization CostOfSalesExcludingDepreciationDepletionAndAmortization	230545	USD
	opgn	Cost Of Sales Excluding Depreciation Depletion And Amortization CostOfSalesExcludingDepreciationDepletionAndAmortization	903754	USD
	opgn	Cost Of Sales Excluding Depreciation Depletion And Amortization CostOfSalesExcludingDepreciationDepletionAndAmortization	613447	USD
CY2015Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	185177	USD
CY2014Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	141060	USD

Files In Submission

Name	View Source	Status
0001144204-15-065342-index-headers.html	Edgar Link	pending
0001144204-15-065342-index.html	Edgar Link	pending
0001144204-15-065342.txt	Edgar Link	pending
0001144204-15-065342-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_002.jpg	Edgar Link	pending
opgn-20150930.xml	Edgar Link	completed
opgn-20150930.xsd	Edgar Link	pending
opgn-20150930_cal.xml	Edgar Link	unprocessable
opgn-20150930_def.xml	Edgar Link	unprocessable
opgn-20150930_lab.xml	Edgar Link	unprocessable
opgn-20150930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v423020_10q.htm	Edgar Link	pending
v423020_ex10-6.htm	Edgar Link	pending
v423020_ex31-1.htm	Edgar Link	pending
v423020_ex31-2.htm	Edgar Link	pending
v423020_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPGN
OPGEN INC Stock $opgn

2015 Q4 Form 10-Q Financial Statement

#000114420415065342 Filed on November 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN OPGEN INC Stock $opgn

2015 Q4 Form 10-Q Financial Statement

#000114420415065342 Filed on November 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN
OPGEN INC Stock $opgn